Page 68 - Cote clinical veterinary advisor dogs and cats 4th
P. 68

Acetaminophen Toxicosis   11


           •  History  of  progressive  lethargy,  anorexia,   increases are typically seen within 24-36   •  Supportive care
                                                  hours of ingestion.
             vomiting, icterus, muddy or cyanotic mucous   •  Spot test for methemoglobinemia: Place one   ○   Oxygen (p. 1146)
  VetBooks.ir  ness, or paw and facial edema    drop of blood on absorbent white paper   ○   Blood  transfusion  may  be  needed  if   Diseases and   Disorders
                                                                                    ○   Fluid therapy to maintain hydration and
             membrane color, tachypnea, dyspnea, weak-
                                                                                      electrolyte balance
                                                from affected patient and compare to one
           PHYSICAL EXAM FINDINGS
           •  Most  often  unremarkable  if  early  in  the   drop of blood from unaffected patient. If   hemolytic anemia develops (p. 1169).
                                                affected patient’s blood appears brown in
             clinical course                    comparison, there is a likely diagnosis of   Chronic Treatment
           •  Lethargy, depression              methemoglobinemia.                •  Ophthalmic cyclosporine until KCS resolves
           •  Chocolate-colored  mucous  membranes                                  (typically 4-6 weeks)
             (methemoglobinemia)               Advanced or Confirmatory Testing   •  Continue SAMe until liver enzymes return
           •  Facial  and/or  paw  edema  (more  common   •  Acetaminophen levels at human hospital for   to normal.
             in cats)                           dogs (ideally run 4 hours after exposure)
           •  Tachypnea, dyspnea               •  Methemoglobin levels (not readily available)  Behavior/Exercise
           •  Tachycardia                      •  Schirmer tear test if suspect KCS  Restricted activity during treatment
           •  Icterus                          •  Centrilobular liver necrosis and congestion
           •  Vomiting                          on histopathology                 Drug Interactions
           •  KCS (rare) (p. 568)                                                 Drugs that induce hepatic microsomal systems
                                                TREATMENT                         (e.g., phenobarbital) may increase acetamino-
           Etiology and Pathophysiology                                           phen toxicity due to increased formation of
           •  When normal biotransformation pathways   Treatment Overview         hepatotoxic metabolites.
             for detoxification (glucuronidation and   After exposure but before signs occur,
             sulfation) are overwhelmed, an oxidative   decontamination with emesis and activated   Possible Complications
             metabolite (i.e.,  N-acetyl-p-benzoquinone   charcoal  is important.  Liver protectant and   KCS, chronic liver disease
             imine  [NAPQI])  is  formed  and  binds  to   antioxidant,  N-acetylcysteine, is advised to
             cellular macromolecules leading to cellular   prevent and treat liver injury and may help   Recommended Monitoring
             necrosis.  If  NAPQI  is  conjugated  with   with methemoglobinemia.  •  Monitoring  liver  enzymes  or  func-
             glutathione, it is detoxified.                                         tion tests every 24 hours for initial 48
           •  Another  metabolite,  para-aminophenol   Acute General Treatment      hours after exposure or until liver injury
             (PAP), may be responsible for development   •  Decontamination,  typically  most  ben-  resolves
             of methemoglobinemia through oxidative   eficial within 2 hours of ingestion (only if   •  Monitoring  for  evidence  of  methemoglo-
             damage.                            asymptomatic)                       binemia in first 12 hours after exposure,
                                                ○   Induction of emesis (p. 1188): Apomor-  followed by hemolytic anemia for 72 hours
            DIAGNOSIS                             phine 0.03 mg/kg IV or 0.04 mg/kg IM   after exposure
                                                  or conjunctivally (canine)      •  Monitor  Schirmer  tear  test  for  evidence
           Diagnostic Overview                  ○   Activated charcoal (p. 1087) 1-2 g/kg PO   of  KCS  during  initial  72  hours  after
           Because exposure is usually witnessed or sus-  with sorbitol, one dose   exposure
           pected, determining dose and risk are important.   •  Liver protectant or antioxidant
           If there is doubt regarding recent exposure,   ○   N-acetylcysteine (Mucomyst) 140 mg/kg    PROGNOSIS & OUTCOME
           acetaminophen concentrations (from a human   loading dose (or 280 mg/kg in large
           hospital) should be considered, although this   overdoses), followed by 70 mg/kg every   •  With prompt and aggressive care, prognosis
           test is not sensitive enough for cats. Assess liver   6 hours for 7-17 doses. Oral and intra-  is usually good.
           enzymes and methemoglobin for suspected   venous (IV) formulations are available.   •  Methemoglobinemia  and  significant  liver
           intoxication.                          Dilute to 5% before giving (dextrose if   injury worsen prognosis, as does underlying
                                                  PO, replacement fluids if IV). If giving   health issues, particularly those involving the
           Differential Diagnosis                 orally, must wait 2-3 hours after admin-  liver.
           •  Hepatic injury: xylitol, aflatoxin, blue-green   istration of activated charcoal. May give
             algae, cycad palms (e.g.,  Cycas revoluta,   IV  N-acetylcysteine concurrently with    PEARLS & CONSIDERATIONS
             Zamia furfuracea), hepatotoxic mushrooms,   activated charcoal.
             salicylates                        ○   S-adenosylmethionine (SAMe) 18-20 mg/  Comments
           •  Methemoglobinemia: benzocaine (Cetacaine)   kg PO q 24h for 2 weeks can be used   •  Owners  may  use  brand  names  as  generic
             in cats, naphthalene, nitrites, chlorates,   instead of N-acetylcysteine if liver issues   terms for OTC pain relievers. Verify active
             phenol, Allium sp., skunk spray      are expected but no methemoglobinemia   ingredient and strength of what the owner
           •  Swollen  face/paws:  insect  bite  or  sting,   occurred or after methemoglobinemia has   thinks was ingested.
             cutaneous adverse drug reaction      resolved.                       •  Emesis  is  not  likely  to  be  beneficial  for
                                                ○   Ascorbic acid (helps reduce methemo-  feline  patients  because  acetaminophen  is
           Initial Database                       globin  to  hemoglobin,  but  efficacy  is   absorbed  very  quickly  (peak  plasma  level
           •  CBC: often unremarkable in initial stages  questionable):  30 mg/kg  q  6-12h  PO     of 10-30 minutes). Activated charcoal may
             ○   Heinz body anemia may occur after   or SQ                          be beneficial if given within 30 minutes of
               methemoglobinemia                ○   Cimetidine (inhibitor of cytochrome P450)   exposure.
           •  Serum biochemical profile: often unremark-  is no longer recommended; its inhibition   •  Glucocorticoids  and  antihistamines  will
             able in initial stages               of microsomal enzymes is considered too   have no effect on paw and facial edema
             ○   Progressive  increase  in  liver  enzymes   slow to be of benefit in dogs. In cats,   because they are not due to an allergic
               (alanine aminotransferase [ALT], alkaline   cimetidine is contraindicated because it   reaction.
               phosphatase [ALP]) until hepatic function   inhibits  N-acetyltransferase 1 (NAT1),
               declines,  then decreases  in blood  urea   which can decrease the conversion of   Technician Tips
               nitrogen (BUN), cholesterol, and albumin   PAP to acetaminophen, putting patients   Check for other active ingredients in products
               with  increasing  total  bilirubin.  Initial   at higher risk for methemoglobinemia.  because acetaminophen can be combined with

                                                      www.ExpertConsult.com
   63   64   65   66   67   68   69   70   71   72   73